Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

@article{MaronaLewicka2005DistinctTP,
  title={Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis},
  author={Danuta Marona-Lewicka and Ronald A. Thisted and David E. Nichols},
  journal={Psychopharmacology},
  year={2005},
  volume={180},
  pages={427-435}
}
RationaleThe effect of LSD in humans has been described as occurring in two temporal phases. The behavioral effects in rats also occur in two temporal phases: an initial suppression of exploration followed by increased locomotor activity.ObjectivesWe decided to investigate this phenomenon from the perspective that the pharmacology might have relevance to the neurochemical mechanisms underlying psychosis.MethodsTwenty-five male Sprague–Dawley rats were trained to discriminate LSD (186 nmol/kg, 0… 
Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
TLDR
The results reported here support and extend the previous conclusion that the delayed temporal effects of LSD are mediated by activation of a dopaminergic system.
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
TLDR
Dopamine D4 receptor activation plays a significant modulatory role in the discriminative stimulus effects in LSD-90-trained rats, most markedly for the later temporal phase of LSD, but has no effect on the cue produced by DOI.
An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
TLDR
It is proposed that chronic treatment of rats with low doses of LSD can serve as a new animal model of psychosis that may mimic the development and progression of schizophrenia, as well as model the established disease better than current acute drug administration models utilizing amphetamine or NMDA antagonists such as PCP.
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats
TLDR
The present results suggest that antagonists of the 5-HT5A receptor may inhibit subjective effects of LSD in rats.
Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
TLDR
Examination of how LSD affects probabilistic reversal learning in healthy humans indicates that LSD impacted a fundamental belief-updating process inherent in the brain which can be leveraged to revise maladaptive associations characteristic of a range of mental disorders.
Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats
TLDR
The results support previous findings regarding the prominent role of serotonergic activities underlying LSDs discriminative stimulus effects in male rats and generalize these findings to female rats.
Changes in global brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
TLDR
It is shown that whole-brain data-driven spatial patterns of LSD effects matched 5-HT2A receptor cortical gene expression in humans, which along with ketanserin effects, strongly implicates the 5- HT2A receptors in LSD’s neuropharmacology.
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
TLDR
The critical role of 5-HT2A in LSD’s mechanism, which informs its neurobiology and guides rational development of psychedelic-based therapeutics is pinched, which strongly implicate the 5- HT2A receptor in LSD's neuropharmacology.
Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert+/− ) mice
TLDR
Results suggest that Sert(+/-) mice may respond to the behavioral effects of LSD in a similar manner to wild-type mice, and no significant interactions between LSD treatment and Sert gene dosage in any of the behavioral domains measured.
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
TLDR
The results provide a relatively comprehensive analysis of mPFC transcriptional regulation in response to chronic LSD, and indicate that the long-term effects of LSD may bear relevance to psychiatric illnesses, including schizophrenia.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol
TLDR
It is suggested that the initial suppressive effects of LSD in the BPM paradigm are dissociable from the subsequent increases in locomotion and that the two effects are mediated via different serotonergic orβ-adrenergic receptors.
The discriminative stimulus properties of LSD: Mechanisms of action
TLDR
The data indicate that the discriminative stimulus properties of LSD may be mediated by post-synaptic serotonin or LSD receptors, and dopamine receptors did not seem to be involved in the LSD stimulus cue.
A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.
TLDR
The possibility that LSD's enhancement of neophobia in rats may be a valid analogue model of its intensification of affective reactions in humans is discussed.
Characterization of the discriminative stimulus properties of centrally administered (−)-DOM and LSD
TLDR
Following pretreatment periods that maximize drug-appropriate responding, central administration of (-)-DOM and LSD was approximately 2.4- and 1.5-times more potent, respectively, than systemic administration.
A characterization of LSD-antagonist effects of pirenperone in the rat
TLDR
It was found that pretreatment with pirenperone caused a parallel shift to the right of the dose-effect curve of LSD, which means that the mixed agonist/antagonist activity of LSD may occur at binding sites for 5-HT1 and5-HT2 in the rat brain.
Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
TLDR
5HT-1A agonists have a different profile of behavioral effects than 5HT-2 agonists and that the two classes of drugs can be differentiated using the same test paradigm, providing further support for the hypothesis that the previously described potentiation of neophobia induced by hallucinogens is due to the activation of 5 HT-2 receptors.
Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats
TLDR
Based on the pharmacological profile of risperidone and the other LSD antagonists, it was concluded that a potent central 5-HT2 and catecholamine antagonism is needed for a potent and complete antagonism of the 0.16 mg/kg LSD-cue.
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
TLDR
The present study investigated the binding and functional properties of LSD and several lysergamide analogs at dopamine D1 and D2 receptors, and provided a basis for evaluating the contribution of D1 receptors to the biobehavioral actions of LSD.
5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat
TLDR
The results suggest that the enhanced behavioral response to amphetamine may be due either to an increased sensitivity of dopaminergic neurons in the mesolimbic area, or to an enhanced release of dopamine by amphetamine.
Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
TLDR
It was concluded that LSD mimics 5-HTP by stimulating a subset of serotonin receptors activated by 5- HTP which are sensitive to ketanserin (serotonin-2?).
...
1
2
3
4
5
...